NFE2L2 and Parkinson disease: Previous studies have suggested that Nrf2, as a promoter of the MAP1B gene, regulated the expression of MAP1B in a Parkinson's disease (PD) model, which then regulated the binding process of microtubules and affects the formation of axons [24].